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Chronic alcohol use can result in many pathological effects including alcoholic liver disease (ALD). While
alcohol is necessary for the development of ALD, only 20–30% of alcoholics develop alcoholic steato-
hepatitis (ASH) with progressive liver disease leading to cirrhosis and liver failure (ALD). This suggests
that while chronic alcohol consumption is necessary it is not sufﬁcient to induce clinically relevant liver
damage in the absence of a secondary risk factor. Studies in rodent models and alcoholic patients show
that increased intestinal permeability to microbial products like endotoxin play a critical role in pro-
moting liver inﬂammation in ALD pathogenesis. Therefore identifying mechanisms of alcohol-induced
intestinal permeability is important in identifying mechanisms of ALD and for designing new avenues for
therapy. Cyp2e1 is a cytochrome P450 enzyme that metabolizes alcohol has been shown to be upre-
gulated by chronic alcohol use and to be a major source of oxidative stress and liver injury in alcoholics
and in animal and in vitro models of chronic alcohol use. Because Cyp2e1 is also expressed in the in-
testine and is upregulated by chronic alcohol use, we hypothesized it could play a role in alcohol-induced
intestinal hyperpermeability. Our in vitro studies with intestinal Caco-2 cells and in mice fed alcohol
showed that circadian clock proteins CLOCK and PER2 are required for alcohol-induced permeability. We
also showed that alcohol increases Cyp2e1 protein and activity but not mRNA in Caco-2 cells and that an
inhibitor of oxidative stress or siRNA knockdown of Cyp2e1 prevents the increase in CLOCK or PER2
proteins and prevents alcohol-induced hyperpermeability. With our collaborators we have also shown
that Cyp2e1 knockout mice are resistant to alcohol-induced gut leakiness and liver inﬂammation. Taken
together our data support a novel Cyp2e1-circadian clock protein mechanism for alcohol-induced gut
leakiness that could provide new avenues for therapy of ALD.
& 2014 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
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Alcohol consumption worldwide is increasing and the negative
consequences of chronic alcohol misuse are a healthcare burden in
the United States and worldwide[1,2]. Chronic alcohol use cannder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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dayam et al., 2004), pancreatic disease [3], neurological problems
[4,5], promotion of several forms of cancer [6,7], and negative ef-
fects on immune function [8]. Perhaps the best known effect of
chronic alcohol use is liver inﬂammation known as alcoholic
steatohepatitis (ASH) which can lead to progressive alcoholic liver
disease (ALD) [2,9–11]. While alcohol is necessary for the devel-
opment of ALD, only 20–30% of alcoholics develop alcoholic
steatohepatitis (ASH) with progressive liver disease leading to
cirrhosis and liver failure (ALD) [11–13] suggesting that while
chronic alcohol consumption is necessary it is not sufﬁcient to
induce clinically relevant liver damage in the absence of a sec-
ondary risk factor. Studies in alcoholic patients and animal models
provide compelling evidence that gut-derived microbial factors
and especially bacterial endotoxin (Lipopolysaccharide, LPS) are
necessary to initiate the hepatic inﬂammatory cascades that are
required for the development of alcohol-induced liver injury
[14–16]. The primary source of endotoxin is the intestine, thus
disruption in intestinal barrier integrity can permit the passage of
LPS into the portal circulation resulting in endotoxemia and pro-
moting inﬂammatory cascades necessary to develop liver pathol-
ogy. Alcohol-induced intestinal hyperpermeability (i.e., leaky gut)
and/or dysbiosis of intestinal bacteria [17,18] may both contribute
to the pathological effects of alcohol [19–22]. Alcohol-induced gut
leakiness is particularly relevant in the etiology of ASH and pro-
gressive ALD. Alcohol universally promotes increased permeability
in intestinal epithelial cells in vitro; however, alcohol consumption
induces intestinal hyperpermeability and endotoxemia in only a
subset of human alcoholics [21,22]. Many studies have in-
vestigated alcohol-induced effects on the intestinal barrier using in
vitro, in vivo animal models, and clinical data [23]; however, these
ﬁndings suggest that, especially in vivo, the mechanisms that cause
alcohol-induced intestinal hyperpermeability are not fully
established.Alcohol metabolism, intestinal permeability, and Cyp2e1
Many of the deleterious effects of alcohol are thought to be the
consequence of alcohol metabolism by-products[24], thus it is
possible that individual variability in alcohol metabolism path-
ways might account for individual susceptibility to alcohol-in-
duced gut leakiness. Several recent studies have shown that al-
cohol and/or alcohol metabolism products such as acetaldehyde
[25] (produced as a by-product of alcohol dehydrogenase, ADH) or
stimulation of inducible nitric oxide synthase (iNOS) [26–28] dis-
rupt intestinal barrier integrity via several mechanisms especially
alterations in tight junction proteins [29–31]. Intestinal epithelial
tight junctions are the major regulators of intestinal permeability
[32,33] thus altering tight junction protein expression and/or
function will certainly impact intestinal barrier function. However,
ADH-induced effects on tight junction proteins are unlikely to fully
explain alcohol-induced intestinal hyperpermeability since Caco-2
intestinal epithelial cells, a widely used cell line for alcohol studies
[23], do not express ADH [34] and yet low dose (0.2%) alcohol
exposure results in marked disruption of Caco-2 cell monolayer
barrier function [26,35].
Alcohol metabolism by Cyp2e1 may be contributing to alcohol-
induced effects on the intestine. It is well-established that:
(1) Cyp2e1 is expressed in Caco-2 cells as well as in both the small
intestine and colon tissue in rodents and humans [36–38];
(2) Cyp2e1 protein is induced in intestinal tissue by chronic al-
cohol feeding in rodents and humans[36,37,39,40] mainly through
post-translational mechanisms rather than mRNA expression [41];
(3) Cyp2e1 is one of the most highly expressed of the CYP450
isoforms in the human intestine [38,42]; and (4) Cyp2e1metabolism of alcohol produces oxidative stress products
[24,36,43] that can contribute to alcohol-induced tissue damage
including reactive oxygen species/reactive nitrogen species (ROS/
RNS) that could mediate disruption of intestinal epithelial per-
meability directly [23,26–28]. Oxidative stress also promotes cell
signaling, cellular damage, and changes to proteins regulating
permeability including tight junction proteins [23,27,28]. Cyp2e1-
mediated alcohol metabolism results in the production of reactive
oxygen species (oxidative stress) and other damaging products
[43–45]. Thus, Cyp2e1-mediated products of alcohol could be the
key mechanism of alcohol-induced gut leakiness and liver injury.
Indeed, we have recently shown that Cyp2e1 protein and activity
are increased in alcohol-treated Caco-2 cell monolayers and alco-
hol-fed rodents with gut leakiness [46]. Moreover, knocking down
Cyp2e1 prevented alcohol-induced disruption of monolayer bar-
rier integrity [46]. Also, alcohol-fed Cyp2e1 knockout mice did not
develop endotoxemia and liver inﬂammation (discussed below)
[47]. Recent ﬁndings by Seitz and Wang provide an intriguing
possibility for a role of intestinal Cyp2e1 as a risk factor for de-
veloping ALD. They showed that small intestine and colonic
Cyp2e1 is induced by alcohol with individual variability in humans
which may be contributing to the subset of individuals that de-
monstrate alcohol-induced intestinal hyperpermeability and liver
pathology [36].Alcohol, gut leakiness, alcoholic steatohepatitis, circadian
rhythms and oxidative stress
Circadian rhythms are 24 h biological patterns of function that
synchronize humans and other organisms with the daily en-
vironmental patterns of light and dark and feeding [48–50] and
are essential for the regulation of a wide range of metabolic and
biological pathways. These rhythms are controlled by an ap-
proximately 24 h cyclic pattern of circadian clock gene expression
(including Per1-3, Clock, etc.) that constitutes the molecular cir-
cadian clock and that this molecular clock is expressed in nearly
every cell in the body [51,52]. In addition, each tissue has 5–20% of
the genome directly controlled by circadian mechanisms and
speciﬁc genes that are under this circadian regulation are unique
for each tissue [53,54]. Recent studies have shown that circadian
mechanisms regulate a signiﬁcant number of intestinal genes and
GI functions [55–58]. Disruption of circadian rhythms (e.g., shift
work) has been implicated as a mechanism for a variety of in-
ﬂammation-mediated disorders such as metabolic syndrome,
obesity, cardiovascular disease, cancer, and intestinal disorders
[57,59–62]. Our laboratory has demonstrated that disruption of
circadian rhythms by altering the light:dark cycle in mice makes
the intestine susceptible to damage by injurious agents [63,64].
We have shown that mice subjected to either environmental (re-
peated light/dark phase shifting) or genetic (ClockΔ19 mutation)
circadian rhythm disruption exhibit increased intestinal perme-
ability and that circadian rhythm disruption markedly exacerbates
alcohol-induced gut leakiness and alcoholic liver disease [65].
Therefore, circadian rhythm disruption may be one mechanism to
promote alcohol-induced intestinal barrier dysfunction and liver
pathology accounting for a subset of alcoholics demonstrating
these features.
Several studies have demonstrated that alcohol disrupts circa-
dian rhythms at the behavioral level [66–68] as well as at the level
of gene transcription in the brain central clock in the SCN [69,70].
Other studies have shown that the liver demonstrates circadian
rhythmicity on functional and molecular levels and alcohol-in-
duced steatohepatitis (ASH) occurs concurrently with disruption
of the circadian rhythms in the liver [71,72]. Thus, alcohol-induced
circadian rhythm disruption in the intestine and/or liver may
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liver pathology. One mechanism accounting for alcohol-induced
effects on the molecular circadian clock may be oxidative stress
[73,74] as the molecular circadian clock has several elements that
are redox sensitive. One recent review states that the circadian
system probably evolved in response to the “Great Oxidation
Event” in response to oxidative stress 2.5 billion years ago [75].
One mechanism for alcohol-induced gut leakiness may involve
a circadian mechanism. Using Caco-2 intestinal epithelial cells [76]
we determined that transepithelial resistance (TER) and ﬂux of the
ﬂuorescent dye FSA [26,77,78] are decreased and increased, re-
spectively, in response to Caco-2 cell alcohol exposure (0.1–0.5%)
with alcohol causing dose- and time-dependent increases in bar-
rier dysfunction [35]. When protein levels of components of the
molecular circadian clock were measured, both CLOCK and PER2
were increased as early as 30 min after alcohol exposure and fur-
ther increased until 240 min (237% and 315%, respectively) [35].
Thus, at a time when monolayers are exhibiting alcohol-induced
hyperpermeability, the levels of these molecular circadian clock
proteins are abnormally elevated. To further investigate the causal
impact of these changes in the circadian proteins, siRNA was used
to knock down gene expression of Clock and Per2 in Caco-2 cells
and this knockdown prevented alcohol-induced effects on barrier
integrity [35]. These data support that alcohol-induced increases
in CLOCK and PER2 proteins is required for alcohol stimulation of
intestinal hyperpermeability in this model. To determine if these
effects were also observed in vivo intestinal tissue from rats
chronically administered alcohol (6 g/kg/day, 10 weeks) and that
exhibited intestinal dysbiosis, intestinal hyperpermeability, en-
dotoxemia, and alcoholic steatohepatitis [18,79] were evaluated
for levels of circadian proteins. Evaluation of PER2 protein levels in
the duodenum and colon intestinal tissue from these alcohol-fed
and control rats show a signiﬁcant alcohol-induced elevation in
intestinal PER2 protein [35]. Thus, both the Caco-2 and in vivo data
support that alcohol stimulation of the circadian clock protein
PER2 occurs at a time when intestinal permeability is elevated and
may be an important factor in alcohol-induced gut leakiness.Fig. 1. Proposed model of alcohol Cyp2e1 clock gene protein regulation of gut
permeability.Alcohol, Cyp2e1, oxidative stress, clock genes and intestinal
hyperpermeability and ASH
Considerable evidence supports a role for liver Cyp2e1-medi-
ated alcohol metabolism in the pathogenesis of alcoholic liver
disease, speciﬁcally via the production of oxidative stress [43,80–
85]. Oxidative stress can impact the intestinal barrier function in a
variety of ways but one potentially important pathway is via in-
ﬂuencing redox sensitive cellular signaling mechanisms [23]. A
number of studies have shown that oxidative stress stimulates the
transcription of clock genes that contain a redox sensitive PAS
domain, including Clock and Per2 [73,75,86–89]. Oxidative stress
generated as a consequence of alcohol metabolism by intestinal
Cyp2e1 may be the driving force increasing CLOCK and PER2 re-
sulting in intestinal hyperpermeability. Using Caco-2 cells exposed
to alcohol (0.2%, 4 h) we determined that Cyp2e1 mRNA was not
increased by alcohol but that both protein expression (93%) as well
as enzymatic activity (69%) [90] were signiﬁcantly increased [46].
We also measured Cyp2e1 protein and mRNA in colon tissue from
BL/6 mice fed a chronic alcohol diet and again found no increase in
Cyp2e1 mRNA but a 73% increase in protein. These data are con-
sistent with previous reports of Cyp2e1 following alcohol ex-
posure in liver cells [41] and chronically alcohol-fed rodents [37].
These results, while intriguing, do not support a causal role of
Cyp2e1 in mediating alcohol-induced intestinal hyperperme-
ability. To establish a causal role, we showed that knocking
down Cyp2e1 in Caco-2 cells via siRNA blocked alcohol-inducedincreases in CLOCK and PER2 proteins and prevented alcohol sti-
mulated hyperpermeability [46]. To determine the relative con-
tribution of oxidative stress in these effects, Caco-2 cells were
pretreated with the anti-oxidantN-acetylcysteine (NAC), which
blocked the alcohol-induced increase in CLOCK and PER2 proteins
as well as intestinal hyperpermeability. Similarly, the oxidant H2O2
mimicked the effects of alcohol on CLOCK and PER2 proteins and
this effect could also be blocked with NAC [46]. These data are in
agreement with data from other labs showing H2O2 stimulates
expression of PER2 protein [87,88]. Several studies have shown
that changes in oxidative stress can regulate circadian clock gene
proteins. Those studies have shown that the function of several
circadian genes, including Clock and Per2, are sensitive to changes
in the cellular redox state resulting from cellular metabolism
[73,89]. Experiments with red blood cells show that redox state
alone in the absence of transcription can regulate circadian
rhythms [91] and cyanobacteria [92].
Together, our data support a novel model in which oxidative
stress resulting from alcohol metabolism by intestinal Cyp2e1
upregulates intestinal CLOCK and PER2 circadian proteins pro-
moting alcohol-induced intestinal hyperpermeability [46] (Fig. 1).
Indeed, Cyp2e1 KO mice fed a binge alcohol diet [47] show blunted
intestinal hyperpermeability, endotoxemia, and liver steatosis and
inﬂammation similar to when wild type mice are treated with the
Cyp2e1 inhibitor chlormethiazole [47]. Taken together, these stu-
dies support that Cyp2e1 not only plays a key role in alcohol-in-
duced liver injury but also promotes intestinal leakiness to gut
microbial contents necessary for alcohol-induced liver injury. This
intestinal mechanism for Cyp2e1-mediated alcohol-induced hy-
perpermeability may be driven by a circadian based mechanism
involving increased oxidative stress burden and is summarized in
Fig. 1.
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Our data support a model in which alcohol metabolism by in-
testinal Cyp2e1 promotes intestinal hyperpermeability through a
circadian clock protein-mediated mechanism. One question that
arises from our studies is where does this mechanism of alcohol-
induced intestinal hyperpermeability ﬁt in with other described
mechanisms for alcohol-induced gut leakiness? The simple answer
is that it is too soon to tell, but we believe it is a signiﬁcant con-
tributor. Our data demonstrate signiﬁcant alcohol-induced eleva-
tion of intestinal Cyp2e1 protein and function [46] as well as in-
testinal PER2 protein [65] in chronically alcohol fed mice. Im-
portantly, together with our collaborators we have shown that
Cyp2e1 knockout mice exhibit blunted intestinal leakiness after
binge alcohol [47]. However, intestinal tissue expression of CLOCK
or PER2 protein were not measured in these mice. Future studies
are planned to determine the intestinal expression of these key
proteins in this Cyp2e1 knockout mouse model at baseline and in
response to alcohol feeding.
Our lab and others have published alternative pathways for
alcohol-induced intestinal hyperpermeability and understanding
how these alternative pathways may dovetail into our current
model is an important next focus of our laboratory. For example,
alcohol-induced oxidative stress, especially via upregulation of
inducible nitric oxide synthase (iNOS) [26,28,93]. Therefore one
current focus of our laboratory is in determining the relationship
between Cyp2e1 and iNOS activation by alcohol. Characterizing
this relationship will be a key next step to understanding alcohol
effects on intestinal barrier function and gut derived endotoxin-
mediated inﬂammation in alcohol associated diseases and how
this circadian-Cyp2e1 mechanism ﬁts together with other me-
chanisms of alcohol-induced gut leakiness [23].
Another key question in light of our data are how might our
data explain the increased leakiness in a subset of alcoholics that
develop ALD? The essential point here is that taken together our
data clearly link disruption of circadian rhythms to increased gut
leakiness with and without alcohol [65]. Therefore we propose
that the degree of circadian disruption in an individual patient
may be one critical difference that makes that subject more sus-
ceptible to alcohol-induced gut leakiness. Thus, subjects with
greater circadian disruption could be more susceptible to negative
alcohol-induced effects on gut leakiness. Alternatively, alcohol is
known to disrupt circadian rhythms [67,69,70,94]. Our data also
link alcohol stimulation itself to disruption of clock gene expres-
sion (circadian disruption) which in turn promotes gut leakiness
[46]. Thus, subject to subject variability in the response of the
circadian clock mechanism to alcohol could also explain differ-
ences in a subset of individuals to alcohol-induced gut leakiness.
One reason for this variability for example could be individual
variability in the ‘anti-oxidant capacity’ (redox state) of intestinal
cells/tissue from a given individual due to diet, stress, or other
factors. Another possibility very relevant to this review could be
differences in individual expression of intestinal and/or liver
Cyp2e1. Finally, there is the element of the effects of microbiota
dysbiosis on gut leakiness. We and others have shown that chronic
alcohol use is associated with dysbiosis of the intestinal microbiota
and gut leakiness in rodents and humans [17,18,95]. We have also
recently shown that circadian disruption promotes dysbiosis of the
intestinal microbiota [96]. Therefore, differences in a subject's in-
testinal microbiota as a result of circadian disruption could sy-
nergize to promote increased gut leakiness in a subset of alcohol
users. Identifying the contribution of each of these above possible
mechanisms to result in gut leakiness and ALD in a subset of in-
dividuals will be a challenge for our studies going forward.
There are several potential therapeutic (translational) implica-
tions of the data described in this review. First, several studiessuggest the use of anti-oxidants to prevent/treat alcohol-induced
gut leakiness. Our studies show that the anti-oxidant NAC pre-
vents the alcohol–Cyp2e1 mediated increase in CLOCK and PER2
that in turn promotes intestinal hyperpermeability [46,47]. Simi-
larly, stimulation of zebraﬁsh cells with H2O2 increases Per2mRNA
expression, an effect that is inhibited with the antioxidant catalase
[87]. In addition, our data demonstrate that the Cyp2e1 inhibitor
chlormethiazole prevents alcohol-induced gut leakiness in mice
[46,47]. Thus, antioxidants or Cyp2e1 inhibitors might therefore be
used to reduce alcohol induced gut leakiness therapeutically. A
second possible therapy is the use of prebiotics such as oats or
probiotics such as Lactobacillus GG because we have shown that
both pre- and probiotics ameliorate intestinal oxidative stress and
gut leakiness in alcohol-fed rodents [79,97,98]. One intriguing
possibility is that these effects may be due in part to lowering the
expression of intestinal Cyp2e1 as one study with probiotics has
shown [99]. This may, in part, be the result of correcting alcohol-
induced intestinal dysbiosis (and oxidative stress) as we have
shown for prebiotics and Lactobacillus GG [18]. A third possible
therapeutic avenue suggested by our data are greater attention to
normalizing circadian disruption in the lifestyle of chronic alcohol
users. Our data demonstrate that circadian mechanisms contribute
to the regulation of intestinal permeability in response to alcohol
whereby environmental or genetic disruption of circadian rhythms
augments alcohol-induced effects on gut leakiness and liver injury
[65]. Thus, perhaps normalization of sleep/wake behavior and
daily routines of chronic alcohol abusers (chronotherapy) could be
beneﬁcial by minimizing the negative effects of alcohol on the gut.
Such approaches have been successful with other diseases such as
obesity and metabolic syndrome as well as psychiatric illness
[59,62].
Studies are currently underway in our laboratory investigating
mechanisms of our observed alcohol-induced effects as well as the
mechanisms of potential therapeutic approaches to mitigate some
of the detrimental effects of alcohol that are mediated by Cyp2e1
byproducts. These studies will help us further deﬁne the novel
mechanisms by which Cyp2e1-mediated by products of alcohol
metabolism promote gut leakiness and liver disease that could
form the basis for new avenues of therapy.Acknowledgments
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